表紙
市場調査レポート

移植の世界市場

Global Transplantation Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 324725
出版日 ページ情報 英文 112 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
移植の世界市場 Global Transplantation Market 2015-2019
出版日: 2015年02月18日 ページ情報: 英文 112 Pages
概要

移植とは、疾患に犯されたり傷ついたりした細胞・組織・臓器を健康なものと交換して、人体を通常の状態に修復する、という処置です。腎臓・肝臓・心臓・肺・腸・膵臓・胸腺などの臓器が移植対象となっています。一部の組織 (角膜・骨・腱・心臓弁・皮膚・神経・静脈) もまた、専用の代替的組織と交換することができます。腎臓移植が世界で最も一般的に行われている移植手術で、肝臓移植・心臓移植がそれに続いています。また、処置件数は角膜・筋骨格移植片の移植が最多となっています。一方、移植手術の際には、移植組織製品や免疫抑制剤、組織保存液なども必要となります。世界の移植市場は、2014〜2019年にかけて、9.36%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、全世界の臓器等の移植市場について分析し、技術の概要や市場の構造、市場規模の動向 (今後5年間の予測値)、製品種類別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブサマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品・サービス

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 概要

  • 南北アメリカ諸国で実施された臓器移植件数
  • 欧州諸国で実施された臓器移植件数
  • アジア太平洋地域で実施された臓器移植件数

第7章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第8章 用途別の市場区分

第9章 製品種類別の市場区分

  • 移植用組織製品市場
  • 免疫抑制剤市場
  • 組織型判定技術・臓器保存液市場
  • 代替的技術市場

第10章 地域区分

  • 南北アメリカ市場
  • 欧州・中東・アフリカ地域 (EMEA) 市場
  • アジア太平洋地域市場

第11章 主要国市場

  • 米国
  • 英国
  • フランス

第12章 購入基準

第13章 市場の成長促進要因

第14章 促進要因とその影響力

第15章 市場の課題

第16章 促進要因・課題の影響力

第17章 市場の傾向

第18章 市場動向とその影響

第19章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
    • 企業合併・買収 (M&A)
  • ベンダー分析
  • その他の著名なベンダー

第20章 主要ベンダーの分析

  • Abbott Laboratories
    • 主要データ
    • 事業概要
    • 事業区分
    • 事業戦略
    • 部門別の市場収益額 (最新値)
    • 市場収益額の比較 (対前年度)
    • 地域別の市場収益額
    • 主要情報
    • SWOT分析
  • Arthrex
  • Biomet
  • Kinetic Concepts
  • Medtronic
  • Novartis
  • Stryker

第21章 関連レポート

図表一覧

目次
Product Code: IRTNTR5301

About Transplantation

Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore the normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, pancreas, and thymus can be transplanted. Some tissues such as cornea, bones, tendons, heart valves, skin, nerves, and veins can also be replaced with specific alternative tissues. Kidney transplantation is the most common transplantation procedure worldwide, followed by liver and heart transplantations. Cornea and musculoskeletal grafts transplantations are the most common tissue transplantation procedures. The following are the products required during a transplantation procedure: transplantation tissue products, immunosuppressant drugs, and organ preservation solutions.

TechNavio's analysts forecast the Global Transplantation market to grow at a CAGR of 9.36 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of Global Transplantation market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of transplantation tissue products, immunosuppressant drugs, and organ preservation solutions. These products are used for many transplantation procedures including

  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancreas transplantation
  • Other transplantation

TechNavio's report, the Global Transplantation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Transplantation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Arthrex
  • Biomet
  • Kinetic Concepts
  • Medtronic
  • Novartis
  • Stryker

Other Prominent Vendors

  • 21st Century Medicine
  • Aastrom Biosciences
  • Accord Healthcare
  • Acologix
  • Actavis
  • Advanced Cell Technology
  • Allosource
  • Arteriocyte
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • Bacterin International
  • Baxter
  • Bellicum Pharmaceuticals
  • Bioactive Regenerative Therapeutics
  • BioCardia
  • BioLife Solutions
  • Bio-Rad Laboratories
  • BioTime
  • Bridge to Life
  • Bristol-Myers Squibb
  • Cell & Tissue Systems
  • Claris Lifesciences
  • CONMED
  • Cryolife
  • Cynata Therapeutics
  • Cytomedix
  • Cytori Therapeutics
  • Dr. F. Kohler Chemie
  • Edwards Lifesciences
  • Exactech
  • Forticell Bioscience
  • GE Healthcare
  • Genzyme
  • Geron
  • GlaxoSmithKline
  • Harvard Apparatus Regenerative Technologies
  • HeartWare
  • Histogenics
  • Humacyte
  • F. Hoffmann-La Roche
  • Integra Lifescience
  • InVivo Therapeutics
  • Johnson & Johnson
  • Kensey Nash
  • Kiadis Pharma
  • Lifeblood Medical
  • Lifeline Scientific
  • Living Cell Technologies
  • Luminex
  • MaxCyte
  • Mesoblast
  • Nanofiber Solutions CTO
  • NeoStem
  • Neuralstem
  • On-X Life Technologies
  • Opexa Therapeutics
  • Organ Recovery Systems
  • Organogenesis
  • Osiris Therapeutics
  • Osteotech
  • Pfizer
  • Pluristem Therapeutics
  • Preservation Solutions
  • Quest Diagnostics
  • ReNeuron
  • RTI Surgical
  • SanBio
  • Smith & Nephew
  • St. Jude Medical
  • StemCells
  • Syncardia Systems
  • Tengion
  • Terumo Medical
  • Teva Pharmaceuticals
  • Thermo Fischer Scientific
  • Thoratec
  • Tissue Genesis
  • ToleroTech
  • TransMedics
  • Veloxis Pharmaceuticals
  • ViaCyte
  • Xvivo Perfusion
  • Zimmer

Market Driver

  • Increased Incidence of Organ Failure
  • For a full, detailed list, view our report

Market Challenge

  • Transplant Rejection
  • For a full, detailed list, view our report

Market Trend

  • Increased Government and NGO Initiatives
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Overview

  • 06.1. Organ Transplants Performed in Americas
  • 06.2. Organ Transplants Performed in Europe Region
  • 06.3. Organ Transplants Performed in APAC Region

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Application

09. Market Segmentation by Product Type

  • 09.1. Global Transplantation Tissue Products Market
    • 09.1.1. Market Size and Forecast
  • 09.2. Global Immunosuppressant Drugs Market
    • 09.2.1. Market Size and Forecast
  • 09.3. Global Tissue Typing Technologies and Organ Preservation Solutions Market
    • 09.3.1. Market Size and Forecast
  • 09.4. Global Alternative Technologies Market
    • 09.4.1. Market Size and Forecast

10. Geographical Segmentation

  • 10.1. Transplantation Market in Americas
    • 10.1.1. Market Size and Forecast
  • 10.2. Transplantation Market in EMEA Region
    • 10.2.1. Market Size and Forecast
  • 10.3. Transplantation Market in APAC Region
    • 10.3.1. Market Size and Forecast

11. Key Leading Countries

  • 11.1. US
  • 11.2. UK
  • 11.3. France

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Vendor Analysis 2014
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Description
    • 20.1.3. Business Segmentation
    • 20.1.4. Business Strategy
    • 20.1.5. Revenue by Business Segmentation
    • 20.1.6. Revenue Comparison 2011 and 2012
    • 20.1.7. Revenue by Geographical Segmentation
    • 20.1.8. Key Information
    • 20.1.9. SWOT Analysis
  • 20.2. Arthrex
    • 20.2.1. Key Facts
    • 20.2.2. Business Overview
    • 20.2.3. Product Groups
    • 20.2.4. Key Locations
    • 20.2.5. Recent Developments
    • 20.2.6. SWOT Analysis
  • 20.3. Biomet
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Product Segmentation by Revenue 2014
    • 20.3.4. Product Segmentation by Revenue 2013 and 2014
    • 20.3.5. Geographical Segmentation by Revenue 2014
    • 20.3.6. Business Strategy
    • 20.3.7. Recent Developments
    • 20.3.8. SWOT Analysis
  • 20.4. Kinetic Concepts
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Business Segmentation
    • 20.4.4. Business Segmentation by Revenue 2013
    • 20.4.5. Sales by Geography
    • 20.4.6. Business Strategy
    • 20.4.7. Recent Developments
    • 20.4.8. SWOT Analysis
  • 20.5. Medtronic
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation by Revenue 2013
    • 20.5.4. Business Segmentation by Revenue 2012 and 2013
    • 20.5.5. Geographical Segmentation by Revenue 2013
    • 20.5.6. Business Strategy
    • 20.5.7. Recent Developments
    • 20.5.8. SWOT Analysis
  • 20.6. Novartis
    • 20.6.1. Key Facts
    • 20.6.2. Business Description
    • 20.6.3. Business Segmentation
    • 20.6.4. Revenue by Business Segmentation
    • 20.6.5. Revenue Comparison 2012 and 2013
    • 20.6.6. Sales by Geography
    • 20.6.7. Business Strategy
    • 20.6.8. Key Developments
    • 20.6.9. SWOT Analysis
  • 20.7. Stryker
    • 20.7.1. Key Facts
    • 20.7.2. Business Overview
    • 20.7.3. Business Segmentation by Revenue 2013
    • 20.7.4. Business Segmentation by Revenue 2012 and 2013
    • 20.7.5. Geographical Segmentation by Revenue 2013
    • 20.7.6. Business Strategy
    • 20.7.7. Recent Developments
    • 20.7.8. SWOT Analysis

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Transplant Procedures Performed Americas 2013
  • Exhibit 3: Transplant Procedures Performed Europe Region 2013
  • Exhibit 4: Transplant Procedures Performed APAC Region 2013
  • Exhibit 5: Global Transplantation Market 2014-2019 (US$ billion)
  • Exhibit 6: Segmentation of Global Transplantation Market by Application
  • Exhibit 7: Segmentation of Global Transplantation Market by Application 2014
  • Exhibit 8: Segmentation of Global Transplantation Market by Product Type
  • Exhibit 9: Segmentation of Global Transplantation Market by Product Type 2014 and 2019
  • Exhibit 10: Global Transplantation Tissue Products Market 2014-2019 (US$ billion)
  • Exhibit 11: Global Immunosuppressant Drugs Market 2014-2019 (US$ billion)
  • Exhibit 12: Global Tissue Typing Technologies and Organ Preservation Solutions Market 2014-2019 (US$ billion)
  • Exhibit 13: Global Alternative Technologies Market 2014-2019 (US$ billion)
  • Exhibit 14: Segmentation of Global Transplantation Market by Product Type 2014-2019 (in billion)
  • Exhibit 15: Segmentation of Global Transplantation Market by Product Type 2014-2019
  • Exhibit 16: Segmentation of Global Transplantation Market by Geography 2014 and 2019
  • Exhibit 17: Transplantation Market in Americas 2014-2019 (US$ billion)
  • Exhibit 18: Transplantation Market in EMEA Region 2014-2019 (US$ billion)
  • Exhibit 19: Transplantation Market in APAC Region 2014-2019 (US$ billion)
  • Exhibit 20: Global Transplantation Market Segmentation by Geography 2014-2019 (US$ billion)
  • Exhibit 21: Global Transplantation Market Segmentation by Geography 2014-2019
  • Exhibit 22: Abbott Laboratories Inc.: Business Segmentation
  • Exhibit 23: Abbott Laboratories Inc.: Revenue by Business Segmentation 2012
  • Exhibit 24: Abbott Laboratories Inc.: Revenue by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 25: Abbott Laboratories Inc.: Revenue by Geographical Segmentation 2012
  • Exhibit 26: Arthrex: Product Groups
  • Exhibit 27: Arthrex: Key Locations
  • Exhibit 28: Biomet: Product Segmentation by Revenue 2014
  • Exhibit 29: Biomet: Product Segmentation by Revenue 2013 and 2014 (US$ million)
  • Exhibit 30: Biomet: Geographical Segmentation by Revenue 2014
  • Exhibit 31: Kinetic Concepts: Business Segmentation 2013
  • Exhibit 32: Kinetic Concepts: Business Segmentation by Revenue 2013
  • Exhibit 33: Kinetic Concepts: Sales by Geography 2013
  • Exhibit 34: Medtronic: Business Segmentation by Revenue 2013
  • Exhibit 35: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 36: Medtronic: Geographical Segmentation by Revenue 2013
  • Exhibit 37: Novartis AG: Business Segmentation
  • Exhibit 38: Novartis AG: Revenue by Business Segmentation 2013
  • Exhibit 39: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 40: Novartis AG: Revenue by Geographical Segmentation 2013
  • Exhibit 41: Stryker: Business Segmentation by Revenue 2013
  • Exhibit 42: Stryker: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 43: Stryker: Geographical Segmentation by Revenue 2013
Back to Top